ImmuneOncia aims to develop immuno-oncology therapeutics

to transform the standard of care in cancer treatment

  • About Us
  • Ethical Management

Ethical Management

ImmuneOncia Code Of Ethics & Conduct
ImmuneOncia Ethical Regulations ImmuneOncia Code Of Ethics & Conduct

Driven by the vision of launching the first immuno-oncology therapeutics in the Korean market and establishing a new benchmark for cancer care, ImmuneOncia is dedicated to advancing human health and happiness. We are committed to fostering a fair and transparent culture of ethical management throughout all our business operations.

To establish clearer guidelines for ethical decision-making and proper business conduct, we have enacted the following Code of Conduct. All ImmuneOncia employees are committed to actively practicing these principles.

  • 01

    We comply with our Code of Conduct and, in the event of a violation, hold ourselves accountable for
    our actions in accordance with the Code.

  • 02

    We will actively cooperate with the Code of Conduct Officer in their fact-finding investigation.

  • 03

    In cases of a possible violation or a question of interpretation concerning this Code of Conduct,
    we shall seek company approval or handle the matter in accordance with the procedures determined by the company.

  • 04

    In the event of unethical conduct, including any action that violates the Code of Conduct,
    we will report the matter in accordance with designated procedures.

  • 05

    Upon discovering or becoming aware of any unethical behavior, including a violation of the Code of Conduct by another person,
    we must report it to the Code of Conduct Officer or CEO, as per company regulations.